Parameter | Group | Total (n = 250) | χ2 | p value | ||
---|---|---|---|---|---|---|
Group I (n = 15) | Group II (n = 202) | Group III (n = 33) | ||||
Age ± SD, years | 73 ± 9.5 | 59 ± 19 | 54.2 ± 12.6 | 59.1 ± 13.9 | 14.56* | < 0.001a |
Male | 8 (63.3%) | 132 (65.3%) | 17 (51.5%) | 157 (62.8%) | 2.93 | 0.23 |
Female | 7 (46.7%) | 70 (34.7%) | 16 (50%) | 93 (37.2%) | ||
Non-smoker | 8 (53.3%) | 111 (55.0%) | 24 (72.7%) | 143 (57.2%) | 3.75 | 0.15 |
Smoker | 7 (46.7%) | 91 (45.0%) | 9 (27.3%) | 107 (42.8%) | ||
Antiplatelet therapy | 3 (20.0%) | 23 (11.4%) | 3 (9.1%) | 29 (11.6%) | 1.24 | 0.53 |
Comorbidities | ||||||
Respiratory | 4 (26.7%) | 89 (44.1%) | 15 (45.5%) | 108 (43.2%) | 1.8 | 0.4 |
Cardiac | 8 (53.3%) | 33 (16.3%) | 4 (12.1%) | 45 (18.0%) | 13.1 | 0.001a |
Diabetes mellitus | 2 (13.3%) | 34 (16.8%) | 5 (15.2%) | 43 (17.2%) | 0.16 | 0.91 |
Hepatic | 4 (26.7%) | 13 (5.9%) | 2 (6.1%) | 18 (7.2%) | 6.2 | 0.04a |
Renal | 2 (13.3%) | 9 (4.5%) | 1 (3.0%) | 12 (4.8%) | 2.66 | 0.26 |